|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.14 CAD | -.--% |
|
-.--% | -26.32% |
EGF Theramed Health Corp. (CNSX:TMED) entered into a Letter of Intent to acquire Nanaimo Dispensary from Kiaro Holdings Corp. (TSXV:KO) for CAD 0.12 million on February 8, 2023.
As for consideration, EGF will purchase all the issued and outstanding capital stock of Kiaro from the Vendors for up to CAD 0.1 million in cash. During the year ended June 30, 2023, the Company advanced CAD 0.02 million as deposit in relation to this proposed transaction.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 0.14 CAD | -.--% | -.--% | 1.17M | ||
| 0.005 CAD | -.--% | -.--% | 162K | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -26.32% | 1.17M | |
| +25.69% | 47.86B | |
| +46.90% | 41.42B | |
| -3.46% | 40.66B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +28.07% | 12.14B | |
| +0.17% | 12.15B | |
| -1.24% | 11.99B |
EGF THERAMED HEALTH CORP. 
